2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one,
2-QHBIQO,
Aloxi,
palonosetron,
palonosetron hydrochloride,
Palonosetron, (3R)-,
palonosetron, (R-(R*,R*))-isomer,
palonosetron, (R-(R*,S*))-isomer,
palonosetron, (S-(R*,S*))-isomer,
RS 25233 197,
RS 25233 198,
RS 25233-197,
RS 25233-198,
RS 25233197,
RS 25233198,
RS 25259,
RS 25259 197,
RS 25259 198,
RS 25259-197,
RS 25259-198,
RS 25259197,
RS 25259198,
RS-25233-197,
RS-25233-198,
RS-25259,
RS-25259-197,
RS-25259-198,
RS25233197,
RS25233198,
RS25259,
RS25259197,
RS25259198,
Palonosetron hydrochloride,
135729-62-3,
PALONOSETRON HCl,
Aloxi,
Palonosetron (Hydrochloride),
Onicit,
UNII-23310D4I19,
RS-25259-197,
(3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one monohydrochloride,
CHEBI:85157,
(S,S)-Palonosetron Hydrochloride,
23310D4I19,
RS 25259-197,
Aloxi (TN),
DSSTox_CID_26610,
DSSTox_RID_81765,
DSSTox_GSID_46610,
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one hydrochloride,
CAS-135729-62-3,
UNII-1J5X5HPB4C,
1J5X5HPB4C,
Onicita,
Paloxi,
palonosetron-hcl,
135729-76-9,
AK162860,
Palonosetron hydrochloride [USAN:JAN],
RS 25233-197,
AC1OCF9K,
(R,S)-Palonosetron HCl,
(S,R)-Palonosetron HCl,
NCGC00166415-01,
CHEMBL1720,
MLS001424202,
SCHEMBL182478,
DTXSID8046610,
CTK8F0325,
OLDRWYVIKMSFFB-SSPJITILSA-N,
Palonosetron hydrochloride (Aloxi),
Palonosetron hydrochloride, (3R)-,
(3aS)-2,3,3a,4,5,6-Hexahydro-2-((3S)-3-quinuclidinyl)-1H-benz(de)isoquinolin-1-one monohydrochloride,
135755-51-0,
1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, monohydrochloride, (3aS)-,
HY-A0021,
KS-00000SN1,
Tox21_112421,
MFCD00939524,
NSC743769,
s3050,
AKOS015895112,
AKOS026751493,
Tox21_112421_1,
AC-1293,
ACN-040771,
API0003734,
CCG-101081,
CCG-221268,
CS-0621,
NC00331,
NSC-743769,
Palonosetron hydrochloride (JAN/USAN),
Palonosetronhydrochloride hydrochloride,
RL01606,
RTC-070923,
NCGC00166415-03,
BC201360,
CC-33456,
CPD000469233,
RS 25259,
SAM001246791,
SMR000469233,
AB0105782,
Palonosetron hydrochloride, >=98% (HPLC),
TC-070923,
FT-0600824,
P-225,
P2051,
D05343,
EN300-221649,
RS 25259 197,
W-5346,
729P623,
A806977,
C-20102,
I14-20251,
(2R,3R,6R)-2-methyl-6-(phenylsulfanyl)-3,6-dihydro-2H-pyran-3-ol,
1H-Benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, (3aS)- hydrochloride,
1H-Benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, [S-(R*,R*)]-, hydrochloride,
Palonosetron hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(3aS)-2-((3S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride,
(3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride,
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one--hydrogen chloride (1/1),
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride.,
(3as)-2-[(s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1-oxo-1h-benz[de]isoquinoline hydrochloride,
(3S)-3-[(3aS)-1-oxo-3a,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-2(3H)-yl]-1-azabicyclo[2.2.2]octan-1-ium chloride,
(S)-2-((S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride,
1H-Benz[de]isoquinolin-1-one, 2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-, hydrochloride (1:1), (3aS)-,
cc-332,
C19-H24-N2-O.Cl-H,
Palonosetron Hydrochloride [USAN],
CID6918303,
CS-T-60134,
B2229,
Palonosetron hydrochloride, 99.5%, a 5-HT3 antagonist - 1G 1g,
135729-61-2,